BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37707961)

  • 1. Factor-inhibiting HIF (FIH) promotes lung cancer progression.
    García-Del Río A; Prieto-Fernández E; Egia-Mendikute L; Antoñana-Vildosola A; Jimenez-Lasheras B; Lee SY; Barreira-Manrique A; Zanetti SR; de Blas A; Velasco-Beltrán P; Bosch A; Aransay AM; Palazon A
    JCI Insight; 2023 Oct; 8(20):. PubMed ID: 37707961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ankyrin Repeat Proteins of Orf Virus Influence the Cellular Hypoxia Response Pathway.
    Chen DY; Fabrizio JA; Wilkins SE; Dave KA; Gorman JJ; Gleadle JM; Fleming SB; Peet DJ; Mercer AA
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of the
    Cai X; Zhang D; Wang J; Liu X; Ouyang G; Xiao W
    J Biol Chem; 2018 Oct; 293(40):15370-15380. PubMed ID: 30126845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-31-5p enhances the Warburg effect via targeting FIH.
    Zhu B; Cao X; Zhang W; Pan G; Yi Q; Zhong W; Yan D
    FASEB J; 2019 Jan; 33(1):545-556. PubMed ID: 30004795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of factor inhibiting HIF (FIH-1) in inhibiting HIF-1 transcriptional activity in glioblastoma multiforme.
    Wang E; Zhang C; Polavaram N; Liu F; Wu G; Schroeder MA; Lau JS; Mukhopadhyay D; Jiang SW; O'Neill BP; Datta K; Li J
    PLoS One; 2014; 9(1):e86102. PubMed ID: 24465898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolyl hydroxylase domain protein 3 and asparaginyl hydroxylase factor inhibiting HIF-1 levels are predictive of tumoral behavior and prognosis in hepatocellular carcinoma.
    Ma M; Hua S; Li G; Wang S; Cheng X; He S; Wu P; Chen X
    Oncotarget; 2017 Feb; 8(8):12983-13002. PubMed ID: 28099905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor inhibiting HIF-1 (FIH-1) modulates protein interactions of apoptosis-stimulating p53 binding protein 2 (ASPP2).
    Janke K; Brockmeier U; Kuhlmann K; Eisenacher M; Nolde J; Meyer HE; Mairbäurl H; Metzen E
    J Cell Sci; 2013 Jun; 126(Pt 12):2629-40. PubMed ID: 23606740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Growth Regulation of Factor Inhibiting Hypoxia-Inducible Factor in Renal Carcinoma Cells].
    Deng S; Yang B; Ren ZJ; Dong Q
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):29-33. PubMed ID: 29737085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockout of Factor-Inhibiting HIF (
    Schützhold V; Gravemeyer J; Bicker A; Hager T; Padberg C; Schäfer J; Wrobeln A; Steinbrink M; Zeynel S; Hankeln T; Becker JC; Fandrey J; Winning S
    J Immunol; 2022 Mar; 208(5):1280-1291. PubMed ID: 35121641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of prolyl-hydroxylases PHD-1, 2 and 3 and of the asparagine hydroxylase FIH in non-small cell lung cancer relates to an activated HIF pathway.
    Giatromanolaki A; Koukourakis MI; Pezzella F; Turley H; Sivridis E; Bouros D; Bougioukas G; Harris AL; Gatter KC
    Cancer Lett; 2008 Apr; 262(1):87-93. PubMed ID: 18187257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor-inhibiting HIF-1 (FIH-1) is required for human vascular endothelial cell survival.
    Kiriakidis S; Henze AT; Kruszynska-Ziaja I; Skobridis K; Theodorou V; Paleolog EM; Mazzone M
    FASEB J; 2015 Jul; 29(7):2814-27. PubMed ID: 25837583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The factor inhibiting HIF regulates T cell differentiation and anti-tumour efficacy.
    Bargiela D; Cunha PP; Veliça P; Krause LCM; Brice M; Barbieri L; Gojkovic M; Foskolou IP; Rundqvist H; Johnson RS
    Front Immunol; 2024; 15():1293723. PubMed ID: 38690263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of hypoxia and hypoxia-inducible factor asparaginyl hydroxylase regulation in chronic kidney disease.
    Faivre A; Dissard R; Kuo W; Verissimo T; Legouis D; Arnoux G; Heckenmeyer C; Fernandez M; Tihy M; Rajaram RD; Delitsikou V; Le NA; Spingler B; Mueller B; Shulz G; Lindenmeyer M; Cohen C; Rutkowski JM; Moll S; Scholz CC; Kurtcuoglu V; de Seigneux S
    Nephrol Dial Transplant; 2023 Sep; 38(10):2276-2288. PubMed ID: 37096392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic analysis of the role of the asparaginyl hydroxylase factor inhibiting hypoxia-inducible factor (FIH) in regulating hypoxia-inducible factor (HIF) transcriptional target genes [corrected].
    Stolze IP; Tian YM; Appelhoff RJ; Turley H; Wykoff CC; Gleadle JM; Ratcliffe PJ
    J Biol Chem; 2004 Oct; 279(41):42719-25. PubMed ID: 15302861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor inhibiting HIF (FIH) recognizes distinct molecular features within hypoxia-inducible factor-α (HIF-α) versus ankyrin repeat substrates.
    Wilkins SE; Karttunen S; Hampton-Smith RJ; Murchland I; Chapman-Smith A; Peet DJ
    J Biol Chem; 2012 Mar; 287(12):8769-81. PubMed ID: 22270367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MYPT1, the targeting subunit of smooth-muscle myosin phosphatase, is a substrate for the asparaginyl hydroxylase factor inhibiting hypoxia-inducible factor (FIH).
    Webb JD; Murányi A; Pugh CW; Ratcliffe PJ; Coleman ML
    Biochem J; 2009 May; 420(2):327-33. PubMed ID: 19245366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family.
    Hewitson KS; McNeill LA; Riordan MV; Tian YM; Bullock AN; Welford RW; Elkins JM; Oldham NJ; Bhattacharya S; Gleadle JM; Ratcliffe PJ; Pugh CW; Schofield CJ
    J Biol Chem; 2002 Jul; 277(29):26351-5. PubMed ID: 12042299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoplasmic location of factor-inhibiting hypoxia-inducible factor is associated with an enhanced hypoxic response and a shorter survival in invasive breast cancer.
    Tan EY; Campo L; Han C; Turley H; Pezzella F; Gatter KC; Harris AL; Fox SB
    Breast Cancer Res; 2007; 9(6):R89. PubMed ID: 18096060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FIH Is an Oxygen Sensor in Ovarian Cancer for G9a/GLP-Driven Epigenetic Regulation of Metastasis-Related Genes.
    Kang J; Shin SH; Yoon H; Huh J; Shin HW; Chun YS; Park JW
    Cancer Res; 2018 Mar; 78(5):1184-1199. PubMed ID: 29259012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitor of nuclear factor-kappaB alpha derepresses hypoxia-inducible factor-1 during moderate hypoxia by sequestering factor inhibiting hypoxia-inducible factor from hypoxia-inducible factor 1alpha.
    Shin DH; Li SH; Yang SW; Lee BL; Lee MK; Park JW
    FEBS J; 2009 Jul; 276(13):3470-80. PubMed ID: 19456861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.